TR200101892T2 - Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı. - Google Patents

Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı.

Info

Publication number
TR200101892T2
TR200101892T2 TR2001/01892T TR200101892T TR200101892T2 TR 200101892 T2 TR200101892 T2 TR 200101892T2 TR 2001/01892 T TR2001/01892 T TR 2001/01892T TR 200101892 T TR200101892 T TR 200101892T TR 200101892 T2 TR200101892 T2 TR 200101892T2
Authority
TR
Turkey
Prior art keywords
prevention
treatment
fanquino
memory disorders
fanquinone
Prior art date
Application number
TR2001/01892T
Other languages
English (en)
Inventor
Nikolas Gerolymatos Panayotis
Xilinas Michel
Original Assignee
P.N. Gerolymatos S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P.N. Gerolymatos S.A. filed Critical P.N. Gerolymatos S.A.
Publication of TR200101892T2 publication Critical patent/TR200101892T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Hafiza bozuklugunun tedavisi veya önlenmesi için fankuinonun (4,7-fenantrolin- 5,6-dion) kullanimi tavsiye edilmektedir. Ayrica, normal bir kisinin ögrenme ve hafizani gelistirmek için bir yöntem de tavsiye edilmektedir, bahsedilen yöntem fankuinonun, opsiyonel olarak bir veya daha fazla farmasötik olarak uygun tasiyici ile birlikte uygulanmasini içerir.
TR2001/01892T 1999-01-07 2000-01-06 Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı. TR200101892T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100005 1999-01-07

Publications (1)

Publication Number Publication Date
TR200101892T2 true TR200101892T2 (tr) 2001-11-21

Family

ID=10943706

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01892T TR200101892T2 (tr) 1999-01-07 2000-01-06 Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı.

Country Status (17)

Country Link
US (1) US7030136B2 (tr)
EP (1) EP1140090B1 (tr)
JP (1) JP2002534386A (tr)
AR (1) AR022215A1 (tr)
AT (1) ATE285235T1 (tr)
AU (1) AU1792200A (tr)
BR (1) BR0008241A (tr)
CA (1) CA2358487C (tr)
DE (1) DE60016892T2 (tr)
DK (1) DK1140090T3 (tr)
ES (1) ES2234559T3 (tr)
HK (1) HK1042039B (tr)
IL (1) IL143903A (tr)
PT (1) PT1140090E (tr)
SI (1) SI1140090T1 (tr)
TR (1) TR200101892T2 (tr)
WO (1) WO2000040244A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009981A1 (en) 1997-08-21 1999-03-04 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of alzheimer's disease
AU2001250573A1 (en) * 2000-04-28 2001-11-12 Michel Xilinas Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using phanquinone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472257A (en) 1973-09-10 1977-05-04 Christiaens Sa A Derivative of 4-hydroxy-5-azacoumarin
AU618520B2 (en) * 1986-12-17 1992-01-02 Glaxo Group Limited Medicaments
US5091391A (en) 1990-08-16 1992-02-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of resisting neurodegenerative disorders
US5705401A (en) 1991-11-12 1998-01-06 The University Of Melbourne Method of assaying for alzheimer's disease
US5866597A (en) * 1993-03-19 1999-02-02 Glaxo Wellcome Inc. Use of triazine compounds for the treatment of memory and learning disorders
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
WO1997046526A1 (en) 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
CZ295118B6 (cs) 1996-08-13 2005-05-18 P. N. Gerolymatos S. A. Farmaceutický prostředek
EP1007048A4 (en) 1997-03-11 2004-09-22 Gen Hospital Corp IDENTIFICATION OF AGENTS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE
WO1999009981A1 (en) * 1997-08-21 1999-03-04 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of alzheimer's disease
US5980914A (en) 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof

Also Published As

Publication number Publication date
JP2002534386A (ja) 2002-10-15
IL143903A (en) 2004-02-08
CA2358487C (en) 2008-11-18
HK1042039A1 (en) 2002-08-02
CA2358487A1 (en) 2000-07-13
US7030136B2 (en) 2006-04-18
WO2000040244A1 (en) 2000-07-13
ATE285235T1 (de) 2005-01-15
HK1042039B (zh) 2005-07-29
DK1140090T3 (da) 2005-04-18
DE60016892T2 (de) 2005-12-15
PT1140090E (pt) 2005-05-31
AR022215A1 (es) 2002-09-04
IL143903A0 (en) 2002-04-21
ES2234559T3 (es) 2005-07-01
AU1792200A (en) 2000-07-24
DE60016892D1 (de) 2005-01-27
EP1140090B1 (en) 2004-12-22
EP1140090A1 (en) 2001-10-10
US20030055078A1 (en) 2003-03-20
SI1140090T1 (en) 2005-06-30
BR0008241A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
CA2263561A1 (en) Thienopyrimidines
SE9503143D0 (sv) New preparation
LU91298I2 (fr) Pioglitazone en association avec la metformine et ses dérivés pharmaceutiquement acceptables-competact
GB0025173D0 (en) Therapeutic agents
GB9917406D0 (en) Compounds
TR200201322T2 (tr) H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı
DK0739212T3 (da) Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom
DZ3154A1 (fr) 1-Amino triazolo(4,3-A)quinazoline-5-ones et/ou-5-thiones inhibitrices de phosphodiestérases IV.
EE200200214A (et) Dipüridamooli või mopidamooli kasutamine sellise ravimi valmistamiseks, mis on ette nähtud fibriinsõltuvate mikrotsirkulatsiooni häirete ennetamiseksja raviks
MY121864A (en) Condensed thienopyrimidines with phosphodiesterase-v inhibiting action.
EP1292279A4 (en) USE OF GLATIRAMER ACETATE (COPOLYMER 1) FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM
NO993670D0 (no) Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikament for behandling av AIDS
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
NO960775D0 (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
EP1229973A4 (en) SWING FOR THE DISABLED
NO984572D0 (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
TR200101892T2 (tr) Hafıza bozukluklarının tedavisi veya önlenmesi için fankuinonun kullanımı.
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
TR199801988T2 (tr) Kalp yetmezliginin endotelin antagonistleri ile tedavisi için yöntem.
TR200002939T2 (tr) Paroksetin maleat
CY2388B1 (en) Rate-controlled transdermal administration of risperidone.
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
FR2797399B1 (fr) Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines